Signaturefd, LLC Editas Medicine, Inc. Transaction History

Signaturefd, LLC

$5.2 Billion
Q3 2024

A detailed history of Signaturefd, LLC transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Signaturefd, LLC holds 9,326 shares of EDIT stock, worth $11,750. This represents 0.0% of its overall portfolio holdings.

Number of Shares

9,326

Previous 1,568 494.77%

Holding current value

$11,750

Previous $7,000 342.86%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	BUY	$3.39 - $5.96 $26,299 - $46,237	7,758 Added 494.77%	9,326 $31,000
Q2 2024 Jul 29, 2024	BUY	$4.67 - $7.28 $261 - $407	56 Added 3.7%	1,568 $7,000
Q1 2024 May 03, 2024	BUY	$7.03 - $11.07 $28 - $44	4 Added 0.27%	1,512 $11,000
Q4 2023 Jan 31, 2024	SELL	$6.25 - $11.11 $5,643 - $10,032	-903 Reduced 37.45%	1,508 $15,000
Q3 2023 Nov 03, 2023	SELL	$6.92 - $9.31 $346 - $465	-50 Reduced 2.03%	2,411 $18,000
Q2 2023 Aug 01, 2023	BUY	$6.36 - $11.47 $2,232 - $4,025	351 Added 16.64%	2,461 $20,000
Q1 2023 Apr 28, 2023	BUY	$7.03 - $11.53 $1,912 - $3,136	272 Added 14.8%	2,110 $15,000
Q4 2022 Jan 27, 2023	BUY	$8.32 - $13.21 $3,144 - $4,993	378 Added 25.89%	1,838 $16,000
Q3 2022 Nov 08, 2022	BUY	$12.16 - $19.42 $1,459 - $2,330	120 Added 8.96%	1,460 $18,000
Q2 2022 Aug 10, 2022	SELL	$9.99 - $21.35 $649 - $1,387	-65 Reduced 4.63%	1,340 $16,000
Q1 2022 May 02, 2022	SELL	$14.08 - $27.63 $492 - $967	-35 Reduced 2.43%	1,405 $27,000
Q4 2021 Jan 25, 2022	BUY	$26.55 - $40.57 $5,655 - $8,641	213 Added 17.36%	1,440 $38,000
Q3 2021 Oct 28, 2021	SELL	$39.27 - $72.94 $2,277 - $4,230	-58 Reduced 4.51%	1,227 $50,000
Q2 2021 Jul 26, 2021	BUY	$31.29 - $56.64 $31,602 - $57,206	1,010 Added 367.27%	1,285 $73,000
Q1 2021 Apr 30, 2021	BUY	$39.71 - $90.58 $3,494 - $7,971	88 Added 47.06%	275 $12,000
Q4 2020 Feb 11, 2021	BUY	$27.07 - $84.35 $1,082 - $3,374	40 Added 27.21%	187 $13,000
Q3 2020 Nov 03, 2020	BUY	$28.06 - $37.16 $1,262 - $1,672	45 Added 44.12%	147 $4,000
Q2 2020 Jul 30, 2020	SELL	$18.5 - $34.34 $18 - $34	-1 Reduced 0.97%	102 $3,000
Q3 2018 Nov 15, 2018	SELL	$27.65 - $38.39 $8,295 - $11,517	-300 Reduced 74.44%	103 $3,000
Q2 2018 Aug 14, 2018	BUY	$31.4 - $41.01 $3,140 - $4,101	100 Added 33.0%	403 $14,000
Q1 2018 May 08, 2018	BUY	$29.84 - $44.08 $9,041 - $13,356	303 New	303 $10,000

Others Institutions Holding EDIT

# of Institutions

248

Shares Held

57M

Call Options Held

410K

Put Options Held

394K

View Full List

About Editas Medicine, Inc.

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $86.6M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

More about EDIT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signaturefd, LLC with notifications on news.

Account